Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Introduction
00:00 • 2min
OOPAT as SIDNIB as Monotherapy in SLE
02:03 • 6min
The Disqualification of Non-Responders in Lupus Trials
07:50 • 2min
Barcetanib in Lupus Nephritis
09:42 • 4min
The Homogeneity of Lupus Nephritis Patients
13:33 • 5min
The Advantages of L-Das Over Remission in the Lupus Cohort
18:11 • 2min
The Benefits of L-L-Das for Lupus Patients
19:41 • 2min
The Benefits of L-L-Das
21:29 • 6min
The Lupus Guidelines: Less Is Better
27:08 • 2min
The Progress in Remission Induction
29:02 • 3min